Literature DB >> 14743824

Barcelona 2002: law, ethics, and human rights. HIV/AIDS-related stigma and discrimination: a conceptual framework.

Peter Aggleton.   

Abstract

Only if we understand where HIV/AIDS-related stigma and discrimination come from, and how they are connected to broader social inequalities and the denial of fundamental human rights, can we develop effective strategies to combat them. This article is a much-condensed version of a keynote presentation given at "Meeting the Stigma Challenge: New Paradigms for Civil Society," a satellite meeting held in Barcelona on 8 July 2002, and sponsored by the Joint United Nations Programme on HIV/AIDS (UNAIDS). The presentation described the conceptual framework underpinning the 2002-2003 World AIDS Campaign, whose theme is "HIV/AIDS-Related Stigma and Discrimination," and whose slogan is "Live and Let Live." In this article, Peter Aggleton provides a conceptual overview of the relationship between the stigma and discrimination associated with HIV and AIDS and the human rights violations that ensue from them, with the goal of demonstrating the interconnectedness of these concerns. He also provides some examples of concrete steps that can be taken to counter the stigma, discrimination, and human rights violations.

Entities:  

Mesh:

Year:  2002        PMID: 14743824

Source DB:  PubMed          Journal:  Can HIV AIDS Policy Law Rev        ISSN: 1496-399X


  2 in total

1.  Prevalence and predictors of HIV-related stigma among institutional- and community-based caregivers of orphans and vulnerable children living in five less-wealthy countries.

Authors:  Lynne C Messer; Brian W Pence; Kathryn Whetten; Rachel Whetten; Nathan Thielman; Karen O'Donnell; Jan Ostermann
Journal:  BMC Public Health       Date:  2010-08-19       Impact factor: 3.295

2.  Stigmatizing attitudes towards people living with HIV/AIDS: validation of a measurement scale.

Authors:  Marianne Beaulieu; Alix Adrien; Louise Potvin; Clément Dassa
Journal:  BMC Public Health       Date:  2014-12-04       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.